5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.51▼ | 7.53▼ | 7.53▼ | 7.56▼ | 7.61▼ |
MA10 | 7.46▼ | 7.46▼ | 7.41▲ | 7.82▼ | 6.81▲ |
MA20 | 7.42▲ | 7.50▼ | 7.53▼ | 7.23▲ | 7.85▼ |
MA50 | 7.66▼ | 7.55▼ | 7.47▼ | 6.82▲ | 6.87▲ |
MA100 | 7.30▲ | 6.95▲ | 6.84▲ | 8.21▼ | 6.20▲ |
MA200 | 6.68▲ | 6.51▲ | 6.80▲ | 7.17▲ | 6.66▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | -0.001▼ | -0.011▼ | 0.007▲ | -0.053▼ |
RSI | 48.839▼ | 48.499▼ | 48.812▼ | 52.887▲ | 49.700▼ |
STOCH | 50.881 | 68.246 | 60.773 | 48.614 | 55.641 |
WILL %R | -73.529 | -58.140 | -58.140 | -48.918 | -49.207 |
CCI | -4.142 | 25.119 | 24.452 | 2.639 | 34.837 |
Monday, June 16, 2025 11:47 AM
Lastly, its wholly owned subsidiary, Corellia, has its own AI drug discovery unit that uses its own dataset to produce drugs. However, they are still in the preclinical stage, so it still remains a ...
|
Saturday, June 14, 2025 05:02 AM
Key Insights Significant control over Champions Oncology by private equity firms implies that the general public ...
|
Saturday, June 14, 2025 01:01 AM
Every investor in Champions Oncology, Inc. (NASDAQ:CSBR) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 30% to be ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 7.95 | 7.95 | 7.27 | 7.45 | 20,034 |
27/06/25 | 7.24 | 7.76 | 7.00 | 7.76 | 40,471 |
26/06/25 | 7.49 | 7.498 | 6.98 | 7.22 | 29,344 |
25/06/25 | 7.71 | 7.78 | 7.04 | 7.57 | 20,657 |
24/06/25 | 8.01 | 8.01 | 7.572 | 7.78 | 9,756 |
23/06/25 | 8.28 | 8.28 | 7.71 | 8.06 | 18,998 |
20/06/25 | 8.58 | 8.58 | 8.1219 | 8.29 | 15,708 |
18/06/25 | 7.87 | 8.41 | 7.87 | 8.40 | 24,645 |
17/06/25 | 7.7056 | 8.3171 | 7.657 | 8.05 | 28,540 |
16/06/25 | 7.67 | 7.95 | 7.12 | 7.61 | 43,326 |
|
|
||||
|
|
||||
|
|